Company Announcements

Change of Remuneration Committee Chair

Source: RNS
RNS Number : 3554F
Porvair PLC
17 April 2025
 

For immediate release                                                                                       17 April 2025


porvair logo

 


Porvair plc

("Porvair" or the "Company")

 

Change of Remuneration Committee Chair

 

The Board of Porvair plc is pleased to announce that Sheena Mackay has succeeded Sally Martin as Chair of the Remuneration Committee with effect from 15 April 2025.  Sally will continue to be the Senior Independent Director and a member of the Remuneration Committee, Nomination Committee and Audit Committee. Sally retains her responsibilities as the designated Director responsible for Employee Engagement.

 

Sheena joined the Board on 28 October 2024 as a Non-Executive Director and has been a member of the Remuneration Committee, Nomination Committee and Audit Committee since her appointment.  Sheena is also a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee. 

 

 

 

For further information, please contact:

 

Porvair plc

01553 765 500

Hooman Caman Javvi, Chief Executive


Chris Tyler, Group Company Secretary




Buchanan Communications

0207 466 5000

Charles Ryland / Stephanie Whitmore / Jack Devoy


 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses.  Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets.  It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKLKFASSEFA